Recombinant SARS-Cov-2 Spike protein (BA.2.86), (HEK293), Biotin Conjugated
Product Specifications
Background
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Gene ID
43740568
Swiss Prot
P0DTC2
Expression System
HEK293
Conjugation
Biotin
Tag
C-T4 foldon domain&His
Source
Recombinant SARS-Cov-2 Spike protein (BA.2.86) is expressed in HEK293 cell with C-T4 foldon domain&His. It contains the amino acid sequence of 16-1213/1273
Applications
Others
Endotoxin
Not Tested
Purity
> 90% as determined by SDS- PAGE
Buffer
Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4) . 5% trehalose is added as a protectant before lyophilization.
Storage Conditions
The product should be stored at -70°C or -20°C.
Species
Others
Gene ID URL
43740568
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680891-100 1x 100 µL
Mucin 6 (MUC6) (CLH5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741234-100 1x 100 µL
Bcl-2 (100/D5 + 124), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400796-100 1x 100 µL
Bcl-2 (BCL2/796), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details